Italy and Switzerland Join Forces in Milan for Cancer Research
On July 9, an important meeting between Italy and Switzerland dedicated to scientific research and innovation took place in Milan. Held at the Innovhub headquarters, the event's main objective was to strengthen collaboration between the two countries in the healthcare sector. Specifically, participants focused on the European Horizon Europe program and the fight against cancer.
This matchmaking workshop was organized by the Agency for the Promotion of European Research (APRE). The goal of these meetings is to enable researchers, universities, and businesses to connect and form new partnerships. Through this initiative, Italian and Swiss experts discussed innovative ideas for joint participation in future European Union funding calls.
At the heart of the discussion was "Mission Cancer," a European initiative aiming to improve the lives of millions of people affected by the disease by 2030. Italy has long been at the forefront of oncological research, and collaborating with Switzerland—renowned for its technological and pharmaceutical excellence—represents a vital opportunity to achieve concrete progress in modern medicine.
Horizon Europe is the European Union's primary funding program for research and innovation. Through this program, Europe provides substantial financial resources for projects tackling major global challenges. The meeting in Milan highlights the importance for Italy of staying connected with international partners to secure these funds and promote national scientific development.
In conclusion, the Milan event marks a significant step forward for scientific cooperation between Italy and Switzerland. Building robust research networks not only aids in finding new treatments but also stimulates the economy and technological innovation within the country. The outcomes of this workshop will be realized in the coming years through the development of successful new medical projects.